Literature DB >> 2426397

Relationship between platelet MAO activity and concentrations of 5-HIAA and HVA in cerebrospinal fluid in chronic pain patients.

L von Knorring, L Oreland, J Häggendal, T Magnusson, B Almay, F Johansson.   

Abstract

Platelet monoamine oxidase (MAO) activity and concentrations of 5-HIAA and HVA in the cerebrospinal fluid (CSF) were estimated in a series of 54 chronic pain patients. Platelet MAO activity was found to correlate, positively to CSF concentrations of 5-HIAA and HVA, which had been adjusted in order to eliminate the influence of age and body height. However, only the correlation with 5-HIAA reached a significant level. When partial correlations were sought, only the positive correlation between platelet MAO activity and CSF 5-HIAA remained. The results support the notion that platelet MAO ia a biological marker for some trait dependent property of the central serotonergic system.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2426397     DOI: 10.1007/bf01262956

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  18 in total

1.  Substrate- and inhibitor-related characteristics of human platelet monoamine oxidase.

Authors:  C H Donnelly; D L Murphy
Journal:  Biochem Pharmacol       Date:  1977-05-01       Impact factor: 5.858

2.  Some observations upon a new inhibitor of monoamine oxidase in brain tissue.

Authors:  J P Johnston
Journal:  Biochem Pharmacol       Date:  1968-07       Impact factor: 5.858

3.  Eye-blink rates and platelet monoamine oxidase activity in chronic schizophrenic patients.

Authors:  W J Freed; J E Kleinman; C N Karson; S G Potkin; D L Murphy; R J Wyatt
Journal:  Biol Psychiatry       Date:  1980-04       Impact factor: 13.382

4.  Monoamine oxidase A and B: a useful concept?

Authors:  T J Mantle; K F Tipton
Journal:  Biochem Pharmacol       Date:  1978-01-01       Impact factor: 5.858

5.  The effect of age on the activity and molecular properties of human brain monoamine oxidase.

Authors:  C J Fowler; A Wiberg; L Oreland; J Marcusson; B Winblad
Journal:  J Neural Transm       Date:  1980       Impact factor: 3.575

6.  idiopathic pain disorder: a critique of pain-prone disorder and a proposal for a revision of the DSM-III category psychogenic pain disorder.

Authors:  J B Williams; R L Spitzer
Journal:  J Nerv Ment Dis       Date:  1982-07       Impact factor: 2.254

7.  Genetics of platelet MAO activity in discordant schizophrenic and normal twins.

Authors:  M A Reveley; A M Reveley; C A Clifford; R M Murray
Journal:  Br J Psychiatry       Date:  1983-06       Impact factor: 9.319

8.  Simultaneous determination of dopamine, DOPAC and homovanillic acid. Direct injection of supernatants from brain tissue homogenates in a liquid chromatography--electrochemical detection system.

Authors:  O Magnusson; L B Nilsson; D Westerlund
Journal:  J Chromatogr       Date:  1980-12-12

9.  A correlation between platelet monoamine oxidase activity and plasma prolactin concentrations in man.

Authors:  J E Kleinman; S Potkin; A Rogol; M S Buchsbaum; D L Murphy; J C Gillin; H A Nasrallah; R J Wyatt
Journal:  Science       Date:  1979-10-26       Impact factor: 47.728

10.  CSF monoamine metabolites in melancholia.

Authors:  M Asberg; L Bertilsson; B Mårtensson; G P Scalia-Tomba; P Thorén; L Träskman-Bendz
Journal:  Acta Psychiatr Scand       Date:  1984-03       Impact factor: 6.392

View more
  3 in total

1.  Platelet monoamine oxidase activity predicts alcohol sensitivity and voluntary alcohol intake in rhesus monkeys.

Authors:  Hanna-Linn Wargelius; Claudia Fahlke; Stephen J Suomi; Lars Oreland; James Dee Higley
Journal:  Ups J Med Sci       Date:  2010-02       Impact factor: 2.384

2.  Platelet MAO in patients with idiopathic pain disorders.

Authors:  B G Almay; L von Knorring; L Oreland
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575

Review 3.  Idiopathic pain and depression.

Authors:  L von Knorring; L Ekselius
Journal:  Qual Life Res       Date:  1994-12       Impact factor: 4.147

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.